A5054667985- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Radiomics and Machine Learning in Medical Imaging
- Urologic and reproductive health conditions
- Bladder and Urothelial Cancer Treatments
- MRI in cancer diagnosis
- Renal cell carcinoma treatment
- Advanced MRI Techniques and Applications
- Genital Health and Disease
- Urinary and Genital Oncology Studies
- Urinary Bladder and Prostate Research
- Urological Disorders and Treatments
- Cardiac, Anesthesia and Surgical Outcomes
- Orthopedic Surgery and Rehabilitation
- Enhanced Recovery After Surgery
- Cancer, Lipids, and Metabolism
- Health Systems, Economic Evaluations, Quality of Life
- Reconstructive Surgery and Microvascular Techniques
- Surgical Simulation and Training
- Advanced X-ray and CT Imaging
- Colorectal Cancer Surgical Treatments
- Advanced Radiotherapy Techniques
- Pediatric Urology and Nephrology Studies
- Medical Imaging Techniques and Applications
- Hormonal and reproductive studies
Fondazione Ricerca Molinette
2020-2025
University of Turin
2016-2025
Lyon Genou Centre Albert Trillat
2023-2024
Onco-Urologie Prédictive
2022-2023
Collaborative Group (United States)
2023
Start Treatment & Recovery Centers
2023
Sorbonne Université
2022-2023
Assistance Publique – Hôpitaux de Paris
2022-2023
Pitié-Salpêtrière Hospital
2022-2023
Azienda Ospedaliero Universitaria San Giovanni Battista
2023
No AccessJournal of UrologyAdult Urology1 Oct 2019Salvage Radical Prostatectomy for Recurrent Prostate Cancer: Morbidity and Functional Outcomes from a Large Multicenter Series Open versus Robotic Approaches Paolo Gontero, Giancarlo Marra, Alessio, Claudia Filippini, Marco Oderda, Fernando Munoz, Estefania Linares, Rafael Sanchez-Salas, Ben Challacombe, Prokar Dasgupta, Sanchia Goonewardene, Rick Popert, Declan Cahill, David Gillatt, Raj Persad, Juan Palou, Steven Joniau, Thierry Piechaud,...
To externally validate the currently available nomograms for predicting lymph node invasion (LNI) in patients with prostate cancer (PCa) and to assess potential risk of complications extended pelvic dissection (ePLND) when using recommended threshold.A total 14 921 patients, who underwent radical prostatectomy ePLND at eight European tertiary referral centres, were retrospectively identified. After exclusion incomplete biopsy or pathological data, 12 009 included. Of these, 609 had undergone...
Abstract Objectives To build a machine learning (ML) model to detect extraprostatic extension (EPE) of prostate cancer (PCa), based on radiomics features extracted from MRI index lesions. Methods Consecutive exams patients undergoing radical prostatectomy for PCa were retrospectively collected three institutions. Axial T2-weighted and apparent diffusion coefficient map images annotated obtain lesion volumes interest feature extraction. Data one institution was used training, selection (using...
To assess the outcomes of multiparametric magnetic resonance imaging (mpMRI) transperineal targeted fusion biopsy (TPFBx) under local anaesthesia.We prospectively screened 1327 patients with a positive mpMRI undergoing TPFBx (targeted cores and systematic cores) anaesthesia, at two tertiary referral institutions, between September 2016 May 2019, for inclusion in present study. Primary were detection clinically significant prostate cancer (csPCa) defined as (1) International Society...
No AccessJournal of UrologyAdult Urology1 Dec 2020Pain in Men Undergoing Transperineal Free-Hand Multiparametric Magnetic Resonance Imaging Fusion Targeted Biopsies under Local Anesthesia: Outcomes and Predictors from a Multicenter Study 1,008 Patients Giancarlo Marra, Junlong Zhuang, Alessandro Marquis, Xiaozhi Zhao, Giorgio Calleris, Yansheng Kan, Marco Oderda, Haifeng Huang, Riccardo Faletti, Qing Zhang, Luca Molinaro, Wei Wang, Laura Bergamasco, Hongqian Guo, Paolo Gontero MarraGiancarlo...
Abstract Objective To investigate the diagnostic accuracy of PI-RADS v2.1 multiparametric magnetic resonance imaging (mpMRI) features in predicting extraprostatic extension (mEPE) prostate cancer (PCa), as well to develop and validate a comprehensive mpMRI-derived score (mEPE-score). Methods We retrospectively reviewed all consecutive patients admitted two institutions for radical prostatectomy PCa with available records mpMRI performed between January 2015 December 2020. Data from one...
The preservation of the bladder neck during robot-assisted radical prostatectomy (RARP) could improve urinary continence recovery and limit risk positive surgical margins (PSMs). We refined our lateral approach to technique compared its outcomes with those standard anterior approach. From a retrospective analysis 599 consecutive RARPs, 171 patients treated were pair-matched 1:1 on basis age, grade, pathological stage. described two approaches in terms basal PSMs, continence, complications....
When performing targeted biopsy (TBx), the need to add systematic biopsies (SBx) is often debated. Aim of study evaluate added value SBx in addition TBx terms prostate cancer (PCa) detection rates (CDR), and test concordance between multiparametric magnetic resonance imaging (mpMRI) findings fusion results location.We performed a retrospective, multicentric that gathered data on 1992 consecutive patients who underwent elastic 2011 2020. A standardized approach was used, with (2-4 cores per...
Focal therapy has emerged as an interesting option for localized low- to intermediate-risk prostate cancer (PCa). Targeted microwave ablation (TMA) is a novel FT modality involving targeted delivery of energy under multiparametric magnetic resonance imaging (MRI)/ultrasound guidance.To describe the step-by-step procedure TMA and report early functional outcomes.This was experimental phase 1-2 trial in 11 patients diagnosed with single, MRI-visible PCa lesion up 12 mm, scored International...
Purpose of review Oligometastatic (om) cancer is considered as a transitional state in between locally confined disease and widespread metastases, accessible to multimodal treatment, combining systemic local therapy. In urothelial bladder (BCa), the definitions approaches this condition are poorly standardised mainly based on retrospective data. We aim portray framework for uro-oncologic terminology omBCa go through latest evidence future perspectives. Recent findings Retrospective registry...
This prospective study aimed to (1) compare the diagnostic performance of
Coronavirus disease 2019 (COVID-19) pandemic has dramatically hit all Europe and Northern Italy in particular. The reallocation of medical resources caused a sharp reduction the activity many disciplines, including urology. restricted availability is expected to cause delay treatment urological cancers negatively influence clinical history cancer patients. In this study, we describe COVID-19 impact on uro-oncological management Piedmont/Valle d'Aosta, estimating its future impact.We...
Currently, the majority of prostate cancer (PCa) recurrences after non-surgical first-line treatment are managed with androgen-deprivation therapy (ADT). Salvage radical prostatectomy (sRP) is a curative alternative to ADT but yields significant morbidity. Preliminary evidence from focal salvage treatments shows similar oncological control lower morbidity compared sRP. Among available ablative energies, irreversible electroporation (IRE) modality that proved promising, especially in treating...